NovoCure (NVCR) Assets (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.04% |
| Dec 31, 2025 | -40.91% |
| Sep 30, 2025 | 9.26% |
| Jun 30, 2025 | -0.23% |
| Mar 31, 2025 | 0.65% |
| Dec 31, 2024 | 1.54% |
| Sep 30, 2024 | 0.81% |
| Jun 30, 2024 | 8.09% |
| Mar 31, 2024 | -2.16% |
| Dec 31, 2023 | -0.02% |
| Sep 30, 2023 | -1.09% |
| Jun 30, 2023 | -1.30% |
| Mar 31, 2023 | -1.45% |
| Dec 31, 2022 | 1.48% |
| Sep 30, 2022 | 0.99% |
| Jun 30, 2022 | 1.08% |
| Mar 31, 2022 | 0.94% |
| Dec 31, 2021 | 1.70% |
| Sep 30, 2021 | 2.13% |
| Jun 30, 2021 | 2.76% |
| Mar 31, 2021 | 1.49% |
| Dec 31, 2020 | 144.05% |
| Sep 30, 2020 | -18.51% |
| Jun 30, 2020 | 5.27% |
| Mar 31, 2020 | 4.80% |
| Dec 31, 2019 | 8.02% |
| Sep 30, 2019 | 9.27% |
| Jun 30, 2019 | 9.71% |
| Mar 31, 2019 | 8.96% |
| Dec 31, 2018 | 7.70% |
| Sep 30, 2018 | 1.82% |
| Jun 30, 2018 | 2.11% |
| Mar 31, 2018 | 14.39% |
| Dec 31, 2017 | 1.15% |
| Sep 30, 2017 | 2.04% |
| Jun 30, 2017 | -2.87% |
| Mar 31, 2017 | -6.19% |
| Dec 31, 2016 | -3.10% |
| Sep 30, 2016 | 16.20% |
| Jun 30, 2016 | -10.21% |
| Mar 31, 2016 | -9.21% |
| Dec 31, 2015 | 76.85% |